LAG-3 operates by attaching to MHC class II molecules on antigen-presenting cells, which suppresses TCR signaling and T cell activation, playing a crucial role in the tumor microenvironment to aid melanoma cells in evading immune detection [158]. The gene discussed is LAG3; the disease is melanoma.